Workflow
三峡新材(600293) - 2025 Q1 - 季度财报
HBSXNBMHBSXNBM(SH:600293)2025-04-24 12:20

Financial Performance - The company's operating revenue for Q1 2025 was CNY 215,930,537.88, a decrease of 30.12% compared to CNY 309,012,387.54 in the same period last year[3]. - The net profit attributable to shareholders was CNY 10,385,842.98, down 61.78% from CNY 27,172,547.20 year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -24,128,432.96, a decline of 203.72% compared to CNY 23,263,638.95 in the previous year[3]. - Basic earnings per share decreased by 50.00% to CNY 0.01 from CNY 0.02 in the same period last year[3]. - The gross profit margin for Q1 2025 was approximately 13.5%, down from 16.0% in Q1 2024[14]. - Net profit for Q1 2025 was ¥7.14 million, a decline of 76.0% from ¥29.66 million in Q1 2024[15]. - The total comprehensive income for Q1 2025 was ¥7.14 million, significantly lower than ¥29.66 million in Q1 2024[15]. Cash Flow - The net cash flow from operating activities was CNY -68,334,386.49, a decrease of 158.99% from CNY -26,385,216.08 year-on-year[3]. - The net cash flow from operating activities for Q1 2025 was -CNY 64,093,086.85, compared to -CNY 55,533,887.46 in Q1 2024[25]. - The company reported a net cash flow from investing activities of -CNY 7,886,199.02 in Q1 2025, a significant decline from a positive cash flow of CNY 2,143,969.29 in Q1 2024[25]. - Cash inflow from financing activities in Q1 2025 was CNY 101,350,000.00, with a net cash flow of CNY 97,283,730.27, compared to -CNY 19,713,186.63 in Q1 2024[25]. - The net increase in cash and cash equivalents for Q1 2025 was CNY 25,304,444.40, contrasting with a decrease of -CNY 73,103,104.80 in Q1 2024[25]. - The ending balance of cash and cash equivalents as of Q1 2025 was CNY 140,465,308.87, up from CNY 131,805,415.40 in Q1 2024[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,400,052,815.36, an increase of 1.82% from CNY 3,339,368,473.98 at the end of the previous year[3]. - Total current assets as of March 31, 2025, amounted to RMB 803,230,474.58, an increase from RMB 731,590,823.23 as of December 31, 2024, reflecting a growth of approximately 9.8%[10]. - Total liabilities as of March 31, 2025, were RMB 1,509,586,647.51, compared to RMB 1,466,213,654.44 at the end of 2024, indicating an increase of approximately 2.9%[11]. - The company's total current liabilities decreased to CNY 1,065,757,508.23 as of March 31, 2025, from CNY 1,152,340,449.39 on December 31, 2024, a reduction of about 7.5%[22]. - The total liabilities slightly decreased to CNY 1,441,818,526.66 as of March 31, 2025, from CNY 1,445,739,299.49 on December 31, 2024[22]. Shareholder Information - The equity attributable to shareholders was CNY 1,754,713,847.67, up 0.60% from CNY 1,744,164,082.00 at the end of the previous year[3]. - The total number of ordinary shareholders at the end of the reporting period was 44,335[6]. - The total equity attributable to shareholders was RMB 1,754,713,847.67, compared to RMB 1,744,164,082.00, indicating a growth of approximately 0.6%[11]. - The company's total equity increased to CNY 1,795,241,048.67 as of March 31, 2025, from CNY 1,769,964,931.94 on December 31, 2024, an increase of about 1.4%[22]. Inventory and Receivables - The company's inventory increased significantly to RMB 277,305,677.16 from RMB 173,289,191.61, representing a growth of about 60.1%[10]. - The accounts receivable decreased to RMB 44,296,129.26 from RMB 56,207,560.16, indicating a decline of approximately 21.2%[10]. - The company's inventory increased significantly to CNY 148,799,874.48 as of March 31, 2025, compared to CNY 69,324,257.16 on December 31, 2024, reflecting a growth of approximately 114.4%[21]. Research and Development - Research and development expenses increased significantly to ¥23.09 million in Q1 2025, compared to ¥6.81 million in Q1 2024, reflecting a growth of 239.5%[14]. - Research and development expenses surged to CNY 22,315,108.88 in Q1 2025, compared to CNY 6,808,908.98 in Q1 2024, indicating an increase of approximately 227.5%[24]. Market Conditions - The main reason for the decline in operating revenue was the drop in market prices of the company's leading products[5].